Enoxaparin sodium and Ra - a phase IV clinical study of FDA data

Summary:

Ra is reported as a side effect among people who take Enoxaparin sodium (enoxaparin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Methotrexate, and have Hypothyroidism.

The phase IV clinical study analyzes which people have Ra when taking Enoxaparin sodium. It is created by eHealthMe based on reports of 24,091 people who have side effects when taking Enoxaparin sodium from the FDA, and is updated regularly.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.

What is Ra?

Ra (rheumatoid arthritis) is found to be associated with 1,591 drugs and 2,119 conditions by eHealthMe. Check the latest studies of Ra.

On May, 06, 2026

24,091 people reported to have side effects when taking Enoxaparin sodium.
Among them, 17 people (0.07%) have Ra.

Among these 17 people:

How long have people been on Enoxaparin sodium when they have Ra? *

What is the gender of people who have Ra when taking Enoxaparin sodium? *

female: 82.35 %
male: 17.65 %

What is the age of people who have Ra when taking Enoxaparin sodium? *

What are other drugs people take besides Enoxaparin sodium? *

What are other side effects people have besides Ra? *

Pneumonia: 5 people, 29.41%
General Physical Health Deterioration (weak health status): 5 people, 29.41%
Thrombocytopenia (decrease of platelets in blood): 4 people, 23.53%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 23.53%
Urinary Tract Infection: 3 people, 17.65%
Nausea (feeling of having an urge to vomit): 3 people, 17.65%
Lung Consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces): 3 people, 17.65%
Pneumonia Escherichia (pneumonia due to bacteria escherichia coli): 3 people, 17.65%
Lung Adenocarcinoma Stage Ii (the cancer has spread to some lymph nodes near the original tumour): 3 people, 17.65%
Fatigue (feeling of tiredness): 3 people, 17.65%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 17.65%
Depression: 2 people, 11.76%
Urinary Tract Infection: 1 person, 5.88%
Gout (uric acid crystals building up in the body): 1 person, 5.88%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.88%
Cancer Pain: 1 person, 5.88%
Cardiac Disorder: 1 person, 5.88%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 5.88%
Embolism Venous (embolus may pass into the arterial system): 1 person, 5.88%
Essential Hypertension (primary hypertension): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Enoxaparin sodium and have Ra?

- Check whether Ra is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enoxaparin sodium:

Enoxaparin sodium (24,181 reports)

Ra treatments and more:

Ra (1,091,833 reports)

Browse all side effects of Enoxaparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ra:

Ra (1,591 drugs)

Browse all the conditions that are associated with Ra:

Ra (2,119 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Enoxaparin sodium) and Enoxaparin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.